Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark Alvino currently holds 62,252 shares of PLASMATECH BIOPHARMACEUTICALS INC (PTBI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Alvino has been a net seller of PTBI stock. They have purchased $0 and sold $337.0K worth of shares.
Mark Alvino's most recent insider trade was on Nov 13, 2025, when they sold 15,000 shares at $4.74 per share.
Mark Alvino serves as Executive at PLASMATECH BIOPHARMACEUTICALS INC (PTBI). They have executed 15 insider transactions totaling $337.0K over their tenure at the company.
Mark Alvino holds the position of Executive at PLASMATECH BIOPHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Mark Alvino has shown a selling trading pattern, with $0 in total purchases and $337.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark Alvino was on May 11, 2015, when they purchased $550.5K worth of PTBI shares. This transaction involved 75,000 shares at $7.34 per share.
Mark Alvino currently owns 62,252 shares of PLASMATECH BIOPHARMACEUTICALS INC (PTBI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark Alvino's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark Alvino has 15 Form 4 filings on record as an insider at PLASMATECH BIOPHARMACEUTICALS INC.
Set alerts for Mark Alvino and 40,000+ other insiders.